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Most crude venom from Polybia paulista is composed of short, linear peptides; however, only ﬁve of these
peptides are structurally and functionally characterized. Therefore, the peptides in this venom were
proﬁled using an HPLC-IT-TOF/MS and MSn system. The presence of type -d and -w ions that are
generated from the fragmentation of the side chains was used to resolve I/L ambiguity. The distinction
between K and Q residues was achieved through esteriﬁcation of the a- and ε-amino groups in the
peptide chains, followed by mass spectrometry analysis. Fourteen major peptides were detected in P.
paulista venom and sequenced; all the peptides were synthesized on solid-phase and submitted to a
series of bioassays. Five of them had been previously characterized, and nine were novel toxins. The
novel peptides correspond to two wasp kinins, two chemotactic components, three mastoparans, and
two peptides of unknown function. The seven novel peptides with identiﬁed functions appear to act
synergistically with the previously known ones, constituting three well-known families of peptide toxins
(wasp kinins, chemotactic peptides, and mastoparans) in the venom of social wasps. These multifunc-
tional toxins can cause pain, oedema formation, haemolysis, chemotaxis of PMNLs, and mast cell
degranulation in victims who are stung by wasps.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The venoms of wasps, bees and ants are generally used both for
self-defence and to repel predators or intruders from their nest
(Palma, 2013). The stings of these insects cause severe pain, local
oedema and erythema caused by an increase in the permeability of
the blood vessels near the skin, local tissue damage and occasion-
ally death in large vertebrates, including humans (Brigatte et al.,
2011). Wasp venoms are composed of low molecular weight com-
pounds, proteins and peptides (Nakajima, 1984), with peptide
components constituting approximately 70% of the venom toxins
(De Souza and Palma, 2009). Different types of inﬂammatory
peptides have been reported in these venoms, including masto-
parans (De Graaf et al., 2009), protonectin-like toxins, chemotactic
peptides and wasp kinins (De Souza et al., 2005).
These peptides contain pharmacological actions including mast
cell degranulation, chemotaxis of polymorphonuclear leukocytes
(PMNL), cytolysis and smooth muscle contraction (Mendes and).Palma, 2006; Palma, 2011). The identiﬁcation of the peptides in
these venoms is important for characterizing the pharmacological
symptoms observed during the envenoming process. This knowl-
edge will to help physicians assist the sting victims. The pharma-
cological properties of wasp venoms have not been fully
investigated because of the limited availability of wasp venom and
the low abundance of each individual peptide in these venoms.
Venom proﬁling is a basic approach to global venom exploration
bymass spectrometry. The data set generated by this proﬁling, with
or without chromatographic separation, produces a global picture
of the venom and reveals the complex composition of venom
(Escoubas et al., 2008a, b). Until a few years ago, studies to elucidate
the molecular complexity of venoms were based on low-resolution
chromatographicmethods, whichwere able to detect only themost
abundant toxins (Escoubas et al., 2008a, b). Traditional fraction-
ation usually requires the use of large-scale biological material with
manual fraction collection and focuses on only the most abundant
toxins while ignoring the minor components. The combination of
high-resolution LC systems with modern mass spectrometers is
making the determination of venom compositions more compre-
hensive and more accurate. Combination techniques, such as LC-
MS, are powerful analytical tools for detecting and sequencing
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2006).
Proteomic and peptidomic studies generally use LC-ESI-MS and
nano-ESI-MS/MS protocols that enable the rapid and sensitive
identiﬁcation and characterization of proteins/peptides. These
experimental approaches have led to the identiﬁcation of approx-
imately 100 different peptide components in snake venoms (Jia
et al., 2006). Similar approaches for venom from scorpions, spi-
ders and marine snails of the genus Conus has resulted in the
identiﬁcation of hundreds of different peptide toxins (Calvette
et al., 2007; Conlon et al., 2006; Dyason et al., 2002; Escoubas,
1998; Escoubas et al., 2008a, b; Newton et al., 2007; Liang, 2008;
Mandal et al., 2007; Bias et al., 2009; Davis et al., 2009). The
chemical diversity of peptides from the venoms of social wasps is
still not well understood. The venom from Agelaia pallipes pallipes
contains nine identiﬁed active peptides (Baptista-Saidemberg et al.,
2011). Meanwhile, the venom of Polybia paulistawas characterized
by mass spectrometry-based strategies as containing dozens of
short peptides (Dias et al., 2014). However, only a few peptide
components have had sequences assigned for these wasp species
(De Souza et al., 2005; Mendes and Palma, 2006; Baptista-
Saidemberg et al., 2011; Rocha et al., 2010) In light of the medical
consequences of social wasp stings in Neotropical regions of the
planet and the complex peptide composition of their venoms, we
used peptides fractionation with reversed-phase chromatography
coupled to electrospray ionization-ion trap-time of ﬂight mass
spectrometry (LC-ESI-IT-TOF/MS) and MSn analysis to proﬁle the
peptidome of the venom from P. paulista, which is one of the most
aggressive species of social wasps from Brazil and Central America.2. Materials and methods
2.1. Biological material
The social wasp Polybia paulista was collected in Rio Claro-SP,
southeast Brazil (S2223051.100; W0473205400) and immediately
frozen and stored at20 C and transported to the laboratory. After
unfreezing the wasps their venom reservoirs of were removed by
dissection with surgical microscissors and washed with 50% (v/v)
acetonitrile (MeCN, Aldrich) containing 0.1% (v/v) triﬂuoroacetic
acid (TFA, Aldrich) and cocktail of protease inhibitors (2 mM AEBSF,
0.3 mM Aprotinin, 130 mM Bestatin, 1 mM EDTA, 14 mM E-64 and
1 mM Leupeptin) (SigmaeAldrich, Saint Louis, USA) to solubilize the
peptides. The extract was centrifuged at 10,000  g for 20 min at
4 C. The resulting pellets were discarded and the supernatant was
lyophilized and stored at 85 C. This extract corresponds to the
peptide-rich fraction.2.2. Animals
Male Swiss mice weighing between 25 and 30 g were used
throughout this study. Mice were housed under controlled hu-
midity at 22 C ± 1 and subjected to a 12 h lightedark cycle in a
sound-attenuated room. Food and water were available ad libitum,
and mice were taken to the testing room at least 1 day before the
experiment. All behavioural testing was performed between 9:00
am and 4:00 pm. Each mouse was used only once. All experiments
were performed in accordance with the guidelines for the ethical
use of conscious animals in pain research, published by the
National Academy of Sciences (http://www.nap.edu/catalog/5140.
html). The procedures were approved by the Institutional Animal
Care Committee at S~ao Paulo State University, UNESP campus Rio
Claro, SP (CEUA-IB-UNESP-CRC, Protocol nº 1984). Efforts were
made to minimize the number of animals used and their suffering.2.3. Venom fractionation
About 45 mg of peptide-rich fraction from P. paulista venom
(corresponding to the material from 10 individuals) was solubilized
in 200 mL 50% (v/v) MeCN and fractionated on an RP-HPLC system
using an X-Bridge BEH 130 C-18 column (100 mm  2.1 mm;
3.5 mm) (Waters, Massachussetts, USA) at a ﬂow rate of 200 mL/min.
The elution was initially performed under isocratic conditions for
5.0 minwith 5% (v/v) MeCN (containing 0.1% (v/v) TFA) followed by
a linear gradient from 5 to 60% (v/v) MeCN (containing 0.1% (v/v)
TFA) between 5.1 and 42.0 min at 28 C. The eluent was monitored
at 215 nm with a UV-DAD detector, mod. SPD-M10A (Shimadzu,
Kyoto, Japan). The fractions were manually collected in 5-mL glass
vials. The homogeneity of each peak was determined by ESI-MS
analysis.
2.4. Mass spectrometric analysis
MS and MSn analyses were conducted on an ion trap/time-of-
ﬂight mass spectrometer (IT-TOF/MS) (Shimadzu, Kyoto, Japan)
equipped with an electrospray ionization source. The instrument
was set to permit the accumulation of all ions in the octapole,
followed by rapid pulsing into the IT for MSn analysis. Then, the
sample entered the TOF sector for accurate mass determinations.
The setting conditions for optimized operations were as follows:
positive mode, electrospray voltage 4.5 kV, CDL temperature
200 C, block heater temperature 200 C, nebulizer gas (N2) ﬂow of
1.5 L/min, trap cooling gas (Ar) ﬂow of 95mL/min, ion trap pressure
1.7  102 Pa, TOF region pressure 1.5  104 Pa, ion accumulation
time 50 ms, collision energy set at 35% both for MS2 and MS3, and
collision gas set to 20%. Instrument calibration was performed us-
ing auto-tuning, carried-out in presence of Na-TFA solution (TFA
0.1% (v/v) 10 mM NaOH at pH 3.5). During auto tuning process the
control parameters for the MS instrument are automatically opti-
mized in accordance with a default protocol deﬁned by the in-
strument producer. After this routine calibration mass spectral
resolution was around 10,000 FWHM, and error around 3.08 ppm.
2.5. Peptide synthesis
The peptides were synthesized by step-wise manual solid phase
synthesis using N-9-ﬂuorophenylmethoxy-carbonyl (Fmoc) chem-
istry with Novasyn TGS resin (NovaBiochem, Germany). Side-chain
protective groups included t-butyl for serine and t-butoxycarbonyl
for lysine. Cleavage of the peptideeresin complexes was performed
by treatment with a mixture of triﬂuoroacetic acid, 1,2-
ethanedithiol, anisole, phenol, and water (82.5:2.5:5:5:5 by vol-
ume, respectively). The cleavage reaction used 10mL of mixture per
gram of complex and was incubated at room temperature for 2 h.
Samples were ﬁltered to remove the resin, and ethyl ether was
added at 4 C to precipitate the crude peptides. The samples were
centrifuged at 1000 g for 15 min at room temperature, and the
supernatant was discarded. The crude peptide pellets were solu-
bilized in water and separated on an RP-HPLC system using a semi-
preparative column (SHISEIDO C18, 250mm 10mm, 5 mm) under
isocratic conditions at a ﬂow rate of 2 mL/min. The elution was
monitored at 215 nm with a UV-DAD detector, mod. SPD-M10A
(SHIMADZU, Kyoto, Japan), and each fraction eluted was manually
collected in 2 mL plastic vials. The homogeneity and correct
sequence of the synthetic peptides were evaluated by comparing
their retention times during RP-HPLC under isocratic conditions, as
reported above for the natural peptides. ESI-MS analysis was also
used to check the purity of peptides (given the presence of a single
molecular ion, equivalent to the expected molecular mass for the
amino sequence of each peptide).
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Peptides (1 mg/mL) were solubilized in 100 mL of 25 mM
ammonium bicarbonate buffer at pH 8.5. A solution of 50 mM
dithiothreitol (DTT) (Amersham Biosciences, Sweden) was pre-
pared in ammonium bicarbonate buffer solution as described
above. An aliquot of 25 mL of DTT solution was added to the sample.
The resulting solution was homogenized, incubated at 40 C for
30 min and then cooled to room temperature. Then, 25 mL of
100 mM iodoacetamide (IAA) (Amersham Biosciences, Sweden) in
the ammonium bicarbonate buffer solution was added to the
mixture. The resulting solution was left to react for 60 min in the
dark at room temperature.
2.7. Acetylation of lysine residues
The acetylation of Lys residues was used to distinguish between
the isobaric amino acid residues of Lys and Gln. The peptides were
submitted to acetylation as follows. The acetylation reagent was
prepared by mixing 20 mL acetic anhydride with 60 mL methanol,
and the peptide of interest (1 nmol) was solubilized in 20 mL of
50 mM ammonium bicarbonate pH 7.0. Then, 50 mL of the acety-
lation reagent was mixed with 20 mL of the peptide solution and
incubated at room temperature (~25 C) for 60 min. Next, the
mixture was lyophilized to dryness and reconstituted in 50%
acetonitrile for analysis by mass spectrometry.
2.8. Biological assays
2.8.1. Haemolytic activity
Washed rat red blood cells (WRRBC) were used to evaluate the
haemolytic activity of the peptides. WRRBC were prepared by
washing 50 mL of Wistar RRBC suspension three times with
physiological saline solution (0.85% (w/v) NaCl and 10 mM CaCl2)
and re-suspending in 50 mL of the same solution. Aliquots of
WRRBC (0.5% v/v) were then incubated at 37 C in the presence of
each synthetic peptide for 120 min with gentle mixing. Samples
were then centrifuged and the absorbance of the supernatants was
measured at 540 nm. The absorbance measured fromWRRBC lysed
in the presence of 1% (v/v) Triton X-100 was considered 100%.
2.8.2. Mast cell degranulation activity
Mast cell degranulation was determined by measuring the
release of b-D-glucosaminidase (co-localized with histamine) in the
presence of the synthetic peptides as modiﬁed by De Souza et al.
(2005). Mast cells were obtained by peritoneal washing of adult
Wistar rats with a solution containing 0.877 g NaCl, 0.028 g KCl,
0.043 g NaH2PO4, 0.048 g KH2PO4, 0.10 g glucose, 0.10 g BSA, 90 mL
of a 2 M CaCl2 solution and 50 mL Liquemine (heparin, ROCHE) in
100 mL water. Mast cells were incubated in the presence of pep-
tides for 15 min at 37 C. After centrifugation, the supernatants
were sampled by a b-D-glucosaminidase assay. Brieﬂy, 50 mL of mast
cell suspension was added to 50 mL of the substrate [3 mg of p-
nitrophenyl-N-acetyl-b-D-glucosaminidine (SigmaeAldrich, Saint
Louis, USA) dissolved in 10 mL of 200 mM sodium citrate at pH 4.5]
and incubated for 6 h at 37 C. The reaction was stopped by the
addition of 150 mL of 0.2 M Tris at pH 9.0 and the absorbance of
coloured product was measured at 405 nm in a microtiter plate
reader (Biotrack, Amersham Bioscience, Sweden). The values are
expressed as the percentage of total b-D-glucosaminidase from
lysed mast cells in the presence of 0.1% (v/v) Triton X-100.
2.8.3. Chemotaxis activity
Chemotaxis was assayed in a speciﬁc multi-chamber apparatus
(Neuro Probe, USA) using polymorphonucleated leukocytes (PMNL)obtained from a subcutaneous inﬂammatory induction in Wistar
rats. A special membrane with 10-mM pores was introduced be-
tween two chemotaxis apparatus parts that were open for leuco-
cytes migration. The total cell concentration was 105 cells/mL. The
upper chambers were ﬁlled with 200 mL of PMNL suspension
(2.7  105 cells/mL in 0.9% (v/v) NaCl solution), and the lower
chambers were ﬁlled with 400 mL of physiological solution con-
taining the synthetic peptides. A polycarbonate membrane (10 mm
pore diameter, Neuro Probe) was placed between the two cham-
bers. The chemotaxis chamber was incubated at 37 C for 1 h. After
incubation, cells in the lower chambers were counted using a
Neübauer chamber. The results are expressed as the number of
migrating cells/mL and transformed in percentages of activity with
respect to the standard peptide HR II peptide used as a positive
control.
2.8.4. Von Frey electronic pressure-meter paw tests for mice
Hyperalgesia was induced by intraplantar (i.pl.) injection of
carrageenan (300 mg) or peptides (10 and 30 mg/50 mL) into one of
the hind paws. Mice were placed in acrylic cages (12  10  17 cm
high) with a wire grid ﬂoor for 15e30 min before testing. During
this adaptation period, the pawswere poked 2e3 times. Before paw
stimulation, the animals were quiet, without exploratory move-
ments or defecation, and were not resting on their paws. In these
experiments, we used a pressure-meter that consisted of a hand-
held force transducer ﬁtted with a 0.5 mm2 polypropylene tip
(electronic von Frey anaesthesiometer, IITC Inc., Life Science In-
struments, Woodland Hills, CA, USA). The investigator applied the
polypropylene tip perpendicularly to the central area of the hind
paw with a gradual increase in pressure. A tilted mirror below the
grid provided a clear view of the animal's hind paw. The test con-
sisted of poking a hind paw to provoke a ﬂexion reﬂex followed by a
clear ﬂinch response after paw withdrawal. In the electronic
pressure-meter test, the intensity of the stimulus was automatically
recorded when the pawwaswithdrawn. Themaximal force applied
was 18 g. The stimulation of the paw was repeated until the animal
presented two similar measurements. If the results were incon-
sistent (i.e., a great difference in the baseline response compared to
the other animals of the experiment), another animal was used. The
results are reported as the D (delta) withdrawal threshold (g),
calculated by subtracting the values obtained in absence of the
peptides, from those obtained in presence of each peptide indi-
vidually. The results are expressed as the percentage of activity in
relation to the positive control (carrageenan).
2.8.5. Evaluation of oedema
Oedema was induced by i.p.l. injection of carrageenan (300 mg)
or secapin-2 (1, 2, 4,10, 30 and 50 mg) into one of the hind paws. The
volume increase (oedema) in each injected paw up to the tibiotarsal
articulation was measured using a digital paquimeter (Mitutoyo,
CD-600 CSX-B model, Brazil). The difference between the values
obtained for both hind paws is expressed as the per cent increase in
paw volume and was used as a measure of oedema.
For evaluation of the nociceptive activity of the peptides, they
were dissolved in sterile saline (0.005, 0.35, 1, 2, 10 and 30 mg) and
administered by i.pl. injection into one hind paw. A hypodermic 26-
G needle was inserted into the skin of the second hind footpad (to
avoid back ﬂow) and the tip of the needle was inserted into the
central area of the hind paw in the same area where ﬁlaments and
the tip of the pressure-meter were applied. The nociceptive activity
was evaluated at different times (0-before treatments, 15, 30, 60,
120, 180, 240, 360, 480 and 1440 min) after treatment and
compared to the control. Carrageenan (Marine Colloids, 300 mg)
was diluted in sterile saline and was used as positive control; sterile
saline was used as a negative control.
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Two-way analysis of variance (ANOVA) was used to compare the
groups and doses over time. The factors analysed were time,
treatments and the time vs. treatment interaction. When a signif-
icant time vs. treatment interaction was detected, a one-way
ANOVA was followed by the Tukey test for each time point to
distinguish dosage effects. One-way ANOVA followed by Tukey test
was also used for doseeresponse curves for a single time point.
Results with P < 0.05 were considered to be signiﬁcant.
3. Results
The fractionation of P. paulista venom revealed 24 peaks,
designated 1 to 24 (Fig. 1). Fractions 1 to 4 correspond to a series of
low molecular mass compounds. Fractions 1 and 4 correspond to
histamine and serotonin, respectively (identiﬁed by comparison
against standard compounds). The components of fractions 2 and 3
were not identiﬁed. Meanwhile, fractions 6 to 19 correspond to
peptides representing different types of inﬂammatory activities
and were the focus of this study. The complete amino acid se-
quences of these peptides were assigned using ESI-IT-TOF-MS and
MSn analysis. The interpretation of themass spectra obtained under
collisional induced decomposition (CID) conditions was accom-
plished by subtracting the m/z values between consecutive b- or y-
ions, which enabled the assignment of the sequences of fourteen
peptides. This procedure permitted almost complete sequence as-
signments, with a few remaining ambiguities with relation to the
isobaric residues I/L and K/Q. The I/L ambiguities for the residues
positioned inside the peptide chain were solved using ion-
fragments of d- and/or w-type, speciﬁc for the fragmentation of
side chain of the I and L residues. The remaining I/L ambiguities in
the C- and N-terminal residues were solved by synthesizing four
sequences for each peptide (with I or L positioned at each termini),
which in turn were submitted to chromatographic analysis (in the
same conditions described above). The retention times of synthetic
peptides were compared to the natural one. To address the K/Q
ambiguity, the samples were derivatized with acetic anhydride andFig. 1. Chromatographic proﬁle for the crude venom of P. paulista by RP-HPLC with a packed
performed under isocratic conditions from 0 to 5.0 minwith 5% (v/v) MeCN (containing 0.1%
TFA) in the interval from 5.1 to 90.0 min. The elution was carried out at 28 C at a ﬂow ratsubmitted to mass spectrometric analysis under CID conditions.
The ε-amino group from the side chain of K residues and the a-
amino group of the N-terminal residue of each peptide become
acetylated, contributing in increments of 42 mass units per acetyl
group that was incorporated in the peptide chain. The side chain of
Q residue does not react with acetic anhydride.
For brevity, we are showing only the MS2 spectra of the peptide
components of each fraction studied without any derivatization
while still showing the I/L and K/Q ambiguities (Fig. 2e5). Under
the chromatographic conditions used in this study, the peptide
components began to elute at 19.8 min (fraction 5). The de-
convolution of the MS2 spectrum of this fraction revealed a pep-
tide component with a molecular mass of 845.42 Da (Fig. S1A in the
supplemental information). The precursor ion with an m/z value
423.71 as [M þ 2H]2þ was selected for fragmentation under CID
conditions (Fig. 2A). Analysis of this spectrum revealed the peptide
sequence to be TGDSPDVR. The molecular mass of the natural
peptide (845.40 Da) is consistent with the C-terminal residue in the
acidic form. Therefore, the complete sequence of this peptide is
TGDSPDVR-OH (Table 1).
In the time between 21.0 and 22.5 min, two overlapping peptide
components eluted (fractions 6A and 6B) with molecular masses of
1073.58 Da (fraction 6A) and 1300.74 Da (fraction 6B) (Fig. S1B and
S1C in the supplemental information). The complete sequencing
interpretation of these peptides revealed: fraction 6A- RPPGFTPFR-
OH, and fraction 6B e RARPPGFTPFR-OH (Table 1). At a retention
time of 24.0 min, the eluted fraction 7 (Fig.1) contained amolecular
mass of 1516.79 Da (Fig.S1D in the supplemental information). The
complete sequence assigned for this peptide was RARPPGFTPFRDT-
OH (Table 1).
Fraction 8 eluted at 27 min with a molecular mass of 628.40 Da
(Fig.S2A of the supplement information); the complete interpre-
tation of this spectrum with the isobaric ambiguities revealed the
sequence ILGTIL-NH2 (Table 1). Fraction 9 eluted at a retention time
of 28.2 min with a molecular mass of 1051.70 Da (Fig. S2B in the
supplemental information); the unambiguous sequence assign-
ment of this peptide component revealed its complete primaryX-Bridge BEH 130 C-18 (Waters) column (100 mm  2.1 mm; 3.5 mm). The elution was
(v/v) TFA), followed by a linear gradient from 5 to 60% (v/v) MeCN (containing 0.1% (v/v)
e of 200 mL/min and monitored at 215 nm.
Fig. 2. MS2 spectra obtained under CID conditions of fractions 5, 6A, 6B, and 7, in the positive mode, with the assignment of a series of b- and y-ions and de-convoluted to interpret
and determine the peptide sequence. Some d- and w-ions that were used diagnostically to eliminate the ambiguity between the isobaric residues I/L are also assigned. The
precursor-ions ofm/z 423.71 as [M þ 2H]2þ,m/z 537.78 as [Mþ 2H]2þ,m/z 651.37 as [Mþ 2H]2þ, andm/z 506.59 as [Mþ 3H]3þwere selected for fragmentation in fractions 5 (A), 6A
(B), 6B (C), and 7 (D), respectively.
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Fig. 3. MS2 spectra obtained under CID conditions of fractions 8, 9, 10, and 11, in the positive mode, with the assignment of a series of b- and y-ions and de-convoluted to interpret
and determine the peptide sequence. Some d- and w-ions that were used diagnostically to eliminate the ambiguity between the isobaric residues I/L are also assigned. The
precursor-ions ofm/z 629.4 as [M þ H]þ,m/z 526.85 as [M þ 2H]2þ,m/z 667.39 as [M þ 2H]2þ, andm/z 520.86 as [M þ 2H]2þwere selected for fragmentation in fractions 8 (A), 9 (B),
10 (C), and 11 (D), respectively.
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Fig. 4. MS2 spectra obtained under CID conditions of fractions 13, 15A, and 15B, in the positive mode, with the assignment of a series of b- and y-ions and de-convoluted to interpret
and determine the peptide sequence. Some d- and w-ions that were used diagnostically to eliminate the ambiguity between the isobaric residues I/L are also assigned. The
precursor-ions of m/z 827.51 as [M þ 2H]2þ, m/z 806.99 as [M þ 2H]2þ, and m/z 817.97 as [M þ 2H]2þ were selected for fragmentation in fractions 13 (A), 15A (B), and 15B (C),
respectively.
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Fig. 5. MS2 spectra obtained under CID conditions of fractions 16, 17, and 19, in the positive mode, with the assignment of a series of b- and y-ions and de-convoluted to interpret
and determine the peptide sequence. Some d- and w-ions that were used diagnostically to eliminate the ambiguity between the isobaric residues I/L are also assigned. The
precursor-ions of m/z 620.41 as [M þ 2H]2þ, m/z 631.40 as [M þ 2H]2þ, and m/z 841.47 as [M þ 2H]2þ, were selected for fragmentation in fractions 16 (A), 17 (B), and 19 (C),
respectively.
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Table 1
Proﬁle of peptides sequenced from the venom of the social wasp P. paulista.
Peptides Sequences Fractions Comments
Wasp kinins
Thr6-Bradykinin R P P G F T P F ReOH 6A Picolo et al., 2010
RA-Thr6-Bradykinin R A R P P G F T P F ReOH 6B Novel peptide
RA-Thr6-Bradykinin-DT R A R P P G F T P F R D T-OH 7 Novel peptide
Chemotactic Peptides
Polybia-CP I L G T I L G L L K S L-NH2 16 De Souza et al., 2005
Polybia-CP 2 I L G T I L G K I L-OH 11 Novel peptide
Polybia- CP 3 I L G T I L G T F KS L-NH2 17 Novel peptide
Protonectin (1e6) I L G T I L- OH 8 Mendes et al., 2004
Mastoparans
Polybia-MP I I D W K K L L D A A K Q I L-NH2 13 De Souza et al., 2005
Polybia-MP II I N W L K L G K M V I D A L-NH2 15A De Souza et al., 2005
Polybia-MP IV I D W L K L R V I S V I D L-NH2 19 Novel peptide
Polybia-MP V I N W H D I A I K N I D A L-NH2 15B Novel peptide
Polybia-MP VI I D W L K L G K M V M-OH 10 Novel peptide
Unknown function
unk-1 I P A G W A I V K VeNH2 9 novel peptide
unk-2 T G D S P D V ReOH 5 novel peptide
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Fraction 10 eluted at 32.0 min with a MS1 spectrum (Fig. S2C in
the supplemental information) that revealed the molecular mass to
be 1332.80 Da. Using the analytical strategies already mentioned
above for the other peptides, the complete sequence of this peptide
was assigned as IDWLKIGKMVM-OH. The peptide component from
fraction 11 eluted at 34.1 min, and its MS1 (Fig. S2D in the
supplemental information) spectrum indicated that its molecular
mass is 1039.72 Da. The use of the protocols mentioned above for
solving the isobaric ambiguities and identiﬁcation of the chemical
nature of the C-terminal residue enabled assignment of the com-
plete sequence of this peptide as ILGTILGKIL-OH (Table 1). Fraction
12 was composed of three peptide components at very low con-
centrations, making it difﬁcult to determine their sequencing.
Therefore, they were not analysed.
The sequence assignment was solved by applying the analytical
strategies for resolving the isobaric ambiguities and identiﬁcation
of the organic function of the C-terminal residue, resulting in the
sequence IDWKKLLDAAKQIL-NH2 (Table 1). Fraction 14 corre-
sponded to a mixture of peptides occurring in tiny amounts and
therefore was not studied.
Fraction 15 eluted from 40.0 to 42.0 min and was composed of
two different peptide components that partially overlapped oneTable 2
Proﬁle of biological activities of the peptides identiﬁed in the venom of the social wasp
Peptides Biological Activities*
Mast cell degranulation Hemolysis
Thr6-Bradykynin þ 
RA-Thr6-Bradykynin þ 
RA-Thr6-Bradykynin-DT þ 
Polybia-CP þ 
Polybia-CP 2 þ 
Polybia- CP 3 þ 
Protonectin (1e6) þ 
Polybia-MP I þþþ þþþ
Polybia-MP II þþþ þ
Polybia-MP IV þþþ þ
Polybia-MP V þþ þþ
Polybia-MP VI þþ þ
unk-1  
unk-2  
(*) All the biological activities were compared against a standard compound as reference f
that no activity was detected for the peptide, while (þ), (þþ), and (þþþ) was established
activities.another. Therefore it was treated as fractions 15A and 15B. The MS1
spectra of the peptides from fractions 15A and 15B (Fig. S3B and S3C
in the supplemental information) indicated molecular masses of
1611.98 Da and 1633.95 Da, respectively. The interpretation of MS2
spectra combined with the use of the speciﬁc analytical strategies
for resolving the isobaric ambiguities, as well the identiﬁcation of
the acidic/amide forms of the C-terminal residue permitted the
complete and unambiguous sequencing of both peptides, with
Fraction 15A as INWLKLGKMVIDAL-NH2 and Fraction 15B as
INWHDIAIKNIDAL-NH2.
Fraction 16 eluted from 41.0 to 41.5 min and consisted of a
peptide with a molecular mass of 1238.82 Da (Fig. S4A in the
supplemental information). The sequence assigned (after solving
the isobaric ambiguities and identiﬁcation of the chemical form of
the C-terminal residue) is ILGTILGLLKSL-NH2 (Table 1). The elution
of fraction 17 occurred at 44 min under RP-HPLC (Fig. 1) with a
molecular mass of 1260.80 Da (Fig. S4B in the supplemental
information); the complete and unambiguous sequence was
ILGTILGTFKSL-NH2 (Table 1). The last peptide that was identiﬁed
eluted at a retention time of 52 min (fraction 19) with a molecular
mass of 1680.95 Da (Fig. S4C in the supplemental information); The
sequence of this peptide was assigned as IDWLKLRVISVIDL-NH2
(Table 1).P. paulista.
PMNLs chemotaxys Hypernociception Oedema formation
 þþ þþ
 þþ þþ
 þþ þþ
þþþ þ þ
þþ þ þ
þþ þ þ
þþ þ þ
þ þþþ þþ
þ þþ þ
þ þþ þ
þ þþ þ
þ þþ þ
þ  
þ  
or each assay, and expressed as percentages in relation to these standards; () means
to represent up to 40%, from 41 to 70%, and from 71 to 100% of standard compounds
Table 3
Amino acid sequence alignment of the wasp kinin peptides identiﬁed in the venom of the social wasp P. paulista, with the sequences of similar peptides from different species
of social wasps.
Wasp species Peptides Amino acid sequences
P. paulista Thr6-Bradykynin R P P G F T P F ReOH
RA-Thr6-Bradykinin R A R P P G F T P F ReOH
RA-Thr6-Bradykinin-DT R A R P P G F T P F R D-OH T- OH
Polistes rothney Polisteskinin-Ra A R R P P G F T P F ReOH
Polistes jadwigae Polisteskinin-Ja R R R P P G F S P F ReOH
Pollistes chiensis Polisteskinin-Ca S K R P P G F S P F ReOH
Vespa mandarínia Vespakinin-Xa A R P P G F S P F ReOH
Vespa analis Vespakinin-Aa G R P P G F S P F R V IeOH
Bradykinina R P P G F S P F ReOH
a Nakajima, 1986.
Table 4
Amino acid sequence alignment of the chemotactic peptides identiﬁed in the venom of the social wasp P. paulista, with the sequences of similar peptides from different species
of social wasps.
Wasp species Peptides Amino acid sequences
P. paulista Polybia-CP I L G T I L G L L K S L-NH2
Polybia-CP 2 I L G T I L G K I L-OH
Polybia-CP 3 I L G T I L G T F K S L-NH2
Protonectarina sylveirae Protonectin(1e6)a I L G T I L-OH
Protonectinb I L G T I L G L L K G L-NH2
Vepula lewisii Ves-CP-Lc F L P I I A K L V S G L-NH2
Vespa mandarinia Ves-CP-Mc F L P I L G K L L S G L-NH2
Vespa crabro Crabrolinec F L P L I L R K I V T A L-NH2
a Mendes et al., 2004.
b Dohtsu et al., 1993.
c Nakajima, 1986.
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aligned with the sequences of known peptides from wasp venoms
(Tables 3e5). The sequence similarities to known peptides were
used for grouping and naming the novel peptides, as shown in
Table 1. The peptides from fractions 13 (IDWKKLLDAAKQIL-NH2)
and 15A (INWLKLGKMVIDAL-NH2) were previously described in P.
paulista venom as themastoparans Polybia-MP I, and Polybia-MP II,
respectively (De Souza et al., 2005; De Souza and Palma, 2009;
Rocha et al., 2010). The peptides from fractions 10, 15B, and 19
were novel mastoparans (Tables 1 and 5) and were named Polybia-
MP IV (fraction 19- IDWLKLRVISVIDL-NH2), Polybia-MP V (fraction
15B e INWHDIAIKNIDAL-NH2), and Polybia-MP VI (fraction 10 e
IDWLKLGKMVM-NH2) (Table 1).
The peptides from fractions 6A, 6B, and 7 were identiﬁed as
members of the family of wasp kinins (Tables 1 and 3). The peptide
in fraction 6A was identiﬁed as Thr6-Bradykinin (RPPGFTPFR-OH),Table 5
Amino acid sequence alignment of the mastoparan peptides identiﬁed in the venom of the
of social wasps.
Wasp species Peptides Amino acid sequences
P. paulista Polybia-MP Ib I D W K K
Polybia-MP IIb I N W L K
Polybia-MP IIIa I D W L K
Polybia-MP IV I D W L K
Polybia-MP V I N W H D
Polybia-MP VI I D W L K
Agelaia pallipes Agelaia-MP IIc I N W K A
Agelaia-MP Ic I N W L K
Vespa xanthoptera Mastoparan Xd I N W K G
Vespa crabro Mastoparan Cd I N W K A
Parapolybia indica Parapolybia-MPd I N L K A
a De Souza et al., 2005.
b De Souza et al., 2005.
c Baptista-Saidemberg et al., 2011.
d Nakajima, 1986.which was previously observed in the venom of the solitary wasp
Cyphononyx fulvognathus (Picolo et al., 2010). Meanwhile, the
peptides in fractions 6B (RARPPGFTPFR-OH) and 7
(RARPPGFTPFRDT-OH) were traditional for this family of peptides,
i.e., RA- Thr6-Bradykinin, and RA- Thr6-Bradykinin-DT, respectively.
The components of fractions 8, 11, 16, and 17 were identiﬁed as
chemotactic peptides for PMNLs (Tables 1 and 4). The peptides of
fractions 8 (ILGTIL-NH2) and 16 (ILGTILGLLKSL-NH2) were previ-
ously reported as chemotactic toxins in social venoms and named
Polybia-CP (De Souza et al., 2005) and Protonectin (1e6) (Baptista-
Saidemberg et al., 2010), respectively. The components in fractions
11 (ILGTILGKIL-OH) and 17 (ILGTILGTFKSL-NH2) were named
Polybia-CP II, and Polybia-CP III, respectively (Tables 1 and 4).
The peptides in fractions 5 (IPAGWAIVKV-NH2) and 9
(TGDSPDVR-OH) did not present any similarity to known peptides
from social wasp venoms and thus were designated as unknownsocial wasp P. paulista, with the sequences of similar peptides from different species
L L D A A K Q I L-NH2
L G K M V I D A L-NH2
L G K M V M D V L-NH2
L R V I S V I D L-NH2
I A I K N I D A L-NH2
L G K M V MeOH
I L Q R I K K M L-NH2
L G K A I I D A L-NH2
I A A M A K K L L-NH2
L L A V A K K I L-NH2
L A A L A K K I L-NH2
N.B. Dias et al. / Toxicon 107 (2015) 290e303300(unk) peptides 1 and 2, respectively. After further study, a novel and
appropriate designation will be given to them.
3.1. Bioassays
Because the peptides proﬁling was performed on-line with an
LC-MS and MS2 system using tiny amounts of P. paulista venom,
samples were not collected for later use in bioassays. All fourteen
peptides that had their sequences completely and unambiguously
assigned were synthesized in the solid phase, puriﬁed and used for
bioassays of mast cell degranulation, haemolysis, chemotaxis of
PMNLs, hypernociception, and oedema formation. These biological
activities are expressed in comparison to the standard compounds
used in each assay; thus, an activity was considered either weak
(þ), medium (þþ), or strong (þþþ) when it represented up to 40%,
from 41% to 70%, or  71% of the activity, respectively.
Peptides were organized into four different groups, which in
turn were submitted to all the bioassays mentioned above. The
group of wasp kinins (Thr6-Bradykinin, RA- Thr6-Bradykinin, and
RA-Thr6-Bradykinin-DT) showedweakmast cell degranulation and
medium hypernociception activity and oedema formation
(Table 2). The group of chemotactic peptides (Polybia-CP, -CP 2, and
-CP 3) showed weak mast cell degranulation, weak hyper-
nociception and weak oedema formation but medium to strong
chemotaxis for PMNLs (Table 2). The mastoparans (Polybia-MP I,
-MP II, -MP IV, -MP V, and eMP VI) showed medium to strong mast
cell degranulation, a range of weak to strong haemolytic activity,
weak chemotaxis for PMNLs, and a range of weak to strong
hypernociception and oedema formation (Table 2). Finally, the
group of unknown peptides (unk-1 and -2) presented only weak
activity of chemotaxis for PMNLs.
4. Discussion
The venoms of social wasps are used by the worker insects as
defensive tools to protect their colonies against attacks by preda-
tors (De Souza and Palma, 2009). Approximately 70% of the dry
weight of wasp venom is composed of peptide toxins (Palma, 2013).
Recently, it was reported that the colonies of P. paulistamay contain
anywhere from 78 to 108 different short linear peptides in the
molecular range of 400e3000 Da (Dias et al., 2014). Despite the
large number of peptides in this venom, only four have been bio-
chemically characterized: Polybia-MP I, -MP II, and -MP III (De
Souza et al., 2005; Mendes and Palma, 2006; Rocha et al., 2010),
and Protonectin (1e6) (Baptista-Saidemberg et al., 2011). To in-
crease our knowledge of the biochemical composition of peptide
toxins from P. paulista, its venom peptidome was proﬁled to iden-
tify some components and their biological activities of these toxins.
Accordingly, P. paulista venomwas fractionated by RP-HPLC, and
analysed by in-line mass spectrometry, constituting an LC-ESI-IT-
TOF-MS and MSn system, as described in Materials and Methods.
The chromatographic proﬁle revealed24major fractions (Fig.1), and
the analytical strategy applied permitted the unambiguous
sequence assignment of fourteen peptides, which were identiﬁed
and functionallyassayed. Thepeptide components fromfractions 6A
(Thr6-Bradykinin), 11 (Polybia-CP 2), 13 (Polybia-MP I), and 15A
(Polybia-MP II) were the most abundant peptides in the chromato-
graphic proﬁle. It is important to emphasize that the wasp venom
was extracted in the presence of a cocktail of proteinase inhibitors,
ensuring that the peptides that the most peptides sequenced were
not by-products of uncontrolled proteolysis of the protein fractions
during venom extraction. However, the occurrence of a few
contaminating peptides is possible, since the venom was obtained
by dissecting the venom reservoirs, which may have resulted in the
leaking of some material from the venom gland tissue.The peptides were identiﬁed by comparison of their sequences
to similar peptide toxins that have previously been characterized
and reported in the literature. A group of wasp kinins was identiﬁed
in P. paulista venom as the peptides in fractions 6A, 6B, and 7, which
were Thr6-Bradykinin, RA-Thr6-Bradykinin, RA-Thr6-Bradykinin-
DT, respectively. The kinins from hymenopteran venoms are
structurally similar to the mammalian pain-producing nonapeptide
bradykinin (BK) (Jackes and Schachter, 1954; Bhoola et al., 1992;
Gobbo et al., 1992; Piek et al., 1983; Yasuhara et al., 1987). Gener-
ally the wasp kinins contain an extra sequence attached to the N-
terminal end of a bradykinin-like peptide (Piek, 1991) as shown in
Table 3. In this study, we describe an uncommon type of wasp kinin
because the peptide RA-Thr6-Bradykinin-DT contains both the
dipeptide RA attached to the N-terminal residue of Thr6-Bradykinin
and the dipeptide DT attached to the C-terminal residue of this
peptide. Some examples of this type are reported in the literature,
including the megascoliakinin (Thr6-BK-Lys-Ala), which was
identiﬁed in the venom of the solitary wasp Megascolia ﬂavifrons
(Piek et al., 1987a, 1987b), as well as the wasp kinin A from Vespa
analis (Nakajima,1986) (Table 3). There are even some peptides that
contain a complete BK sequence within the wasp kinin peptide
chain (Nakajima, 1986). Most of the kinin-related peptides in ani-
mal venoms have longer peptide chains and their actions are
longer-lasting than BK (Piek, 1991). Thr6-Bradykinin is a neurotoxic
component that has already been reported in the venom of solitary
wasps M. ﬂavifrons and Colpa interrupta (Piek et al., 1987a, 1987b),
but it is being reported for the ﬁrst time in the venom of P. paulista.
Wasp kinins cause hypertension in mammals, hypotension in
chickens, bronchoconstriction in rodents, and the contraction of a
series of isolated smoothmuscle preparations, and the relaxation of
the rat duodenum (Edery et al., 1978). The function of kinin-related
peptides in wasp venoms is still not clearly understood. These
peptides can activate leukocytes, stimulating the releasing of cy-
tokines, prostaglandins, leukotrienes, reactive oxygen species and
the blockage of the cholinergic transmission in the insect central
nervous system (CNS) (Mendes and Palma, 2006; Piek,1991). In this
study, three wasp kinin peptides caused weak mast cell degranu-
lation and pain and oedema formation. These observations suggest
that wasp kinins may be used as toxins for defence against mam-
mals and/or birds, which are predators of social wasp colonies,
causing physical discomfort in the victims of their stings.
The second group of peptides identiﬁed in P. paulista venomwas
related to the chemotaxis of PMNLs: fractions 8 (Protonectin (1e6)),
11 (Polybia-CP 2), 16 (Polybia-CP), and 17 (Polybia-CP 3) represent
components of chemotactic peptides family. These peptides cause
massive recruitment of PMNLs, inducing them to deliver large
amounts of oxygen peroxide around the site of wasps stings,
resulting in hyperoxidation in the surrounding tissues, followed by
subsequent cellular death (Palma, 2013).
The venoms of social wasps generally contain two different
types of chemotactic peptides. The ﬁrst is the classical deca- and
dodecapeptides, which contain a single K residue between posi-
tions 8 and 10 of the peptide chain and can induce chemotaxis in
leukocytes (Baptista-Saidemberg et al., 2010; Mendes et al., 2004).
The second type consists of a series of small chemotactic peptides
(from tetra-to octapeptides) that act in modulating the chemo
attraction of leukocytes. This second type also inhibit catechol-
amine secretion by non-competitively blocking speciﬁc acetylcho-
line receptors, but without affecting the catecholamine release that
is caused in the presence of high concentrations of potassium ions
(Monoi et al., 2004). These peptides appear to be natural proteolytic
products of serine-proteinases on mastoparans and chemotactic
peptides (Xu et al., 2006). Of the peptides identiﬁed in the present
study, Polybia-CP, Polybia-CP 2, and Polybia-CP 3 are representative
of the ﬁrst type of chemotactic components, whereas Protonectin
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chemotaxis of PMNLs, these peptides also contained mast cell
degranulation activity, hypernociception, and oedema formation,
which corroborate the multifunctional nature of the toxins.
Table 4 shows an alignment of the four chemotactic peptides
that were observed in P. paulista venom, in comparison to similar
peptides isolated from other wasp species. The peptide Polybia-CP
was previously reported in the same venom (Mendes et al., 2004),
whereas the Polybia-CP 2 and Polybia-CP 3 peptides are novel
toxins. Protonectin was previously reported in the venom of the
social wasp Protonectarina sylveirae (Dohtsu et al., 1993), Agelaia p.
pallipes (Mendes et al., 2004), and Polistes rothneyi iwatai (Polistes-
Protonectin) (Murata et al., 2009). It is notable that protonectin
(1e6) is the only peptide of this group with the C-terminal residue
in its free acid form; the other peptides contain amides at this
position. A comparison of the sequence of Polybia-CP and Proto-
nectin reveals that the only difference is the presence of an S at the
11th position of Polybia-CP, whereas this position is G in Proto-
nectin (Table 4). Table 4 also reveals an interesting structural
feature of this group of toxins, in that the chemotactic peptide
isolated from the venoms of social wasps that are endemic to the
Neotropics (P. paulista and P. sylveirae) contain a highly conserved
sequence ILGTIL; this motif may be considered a molecular signa-
ture of this group. Meanwhile, the chemotactic peptides isolated
from wasps species that are endemic to the northern hemisphere
(Vepula lewisii, Vespa mandarinia, and Vespa crabro) have the
sequence FLP at the N-terminal region as their molecular signature.
The third group of peptides identiﬁed in P. paulista venom are
represented by the mastoparans, which were in fraction 13 (Poly-
bia-MP I), fraction 15A (Polybia-MP II), fraction 19 (Polybia-MP IV),
fraction 15B (Polybia-MP V), and fraction 10 (Polybia-MP VI
(Table 1). These peptides constitute the most numerous and
abundant toxins in P. paulista venom. Mastoparans cause potent
mast cell degranulation and also may cause haemolysis, PMNLs
chemotaxis, hypernociception, and oedema formation, which were
conﬁrmed by the bioassays summarized in Table 2. Typically, most
mastoparans are tetradecapeptides containing from two to four K
residues at positions 4/5 and/or 11/12 and an amide C-terminal
residue (Dos Santos Cabrera et al., 2009). The positioning of K
residues at these sites can contribute to ﬂanking and maintaining
stable helical chains as well as a more homogeneous hydrophobic
surface for these molecules in an amphipathic structure. Such a
surface could contribute to the lytic activity of these peptides (De
Souza and Palma, 2008; De Souza et al., 2011). This structural
feature also gives the mastoparans antimicrobial activity and the
potential to cause cytolytic action in animal cells (Dos Santos
Cabrera et al., 2008).
It has been reported that mastoparans play important roles in
allergy and inﬂammation because they activate exocytosis and
granule fusion with the plasma membrane, with the consequent
releasing of histamine, proteases, lipid mediators and cytokines
(Puri and Roche, 2008). Mastoparans act on mast cells through two
mechanisms: binding to speciﬁc sites of the Ga-subunit of hetero-
trimeric G-protein receptors, stimulating the guanine nucleotide
exchange and leading to a cascade of events, including an increase
in the intracellular levels of Caþ2 ions, which in turn activates a
downstream cascade that results in exocytosis; and binding to
speciﬁc proteins in endosomal membranes, which activates a Caþ2-
independent FcεRI-mediated exocytosis pathway (Chahdi et al.,
2004; Miles et al., 2004; Santos et al., 2012). Mastoparan peptides
are multifunctional toxins that are involved at different levels to
produce pain, oedema and inﬂammation.
Table 5 shows the alignment of the mastoparans that were
identiﬁed in this study compared to those previously identiﬁed in
the venom of the same wasp species as well as in other social waspvenoms. The peptides Polybia-MP I and Polybia-MP II were also
identiﬁed in this study but were already reported in a previous
investigation by our group (De Souza and Palma, 2009). The peptide
Polybia-MP III was previously identiﬁed in P. paulista venom (De
Souza et al., 2005) but was not observed in the present investiga-
tion. The mastoparans Polybia-MP IV, Polybia-MP V, and Polybia-
MP VI constitute novel peptide toxins in this venom. It is impor-
tant to emphasize that the only mastoparan peptide that has been
reported to contain a C-terminal residue in free acidic form is the
Polybia-MP VI, which in turn, is poorly active in relation to all the
activities assayed in the present study. These results support the
expected structure/activity relationship for a mastoparan peptide
in this condition (Saidemberg et al., 2011; Sforza et al., 2004; Silva
et al., 2014). Most mastoparans already reported in the literature
contain a molecular signature in the motif IDW or INW in the N-
terminal region of the peptide chain as is shown in Table 5.
Two novel peptides were identiﬁed in fractions 5 (unk-2) and 9
(unk-1), which containedweakmast cell degranulation activity, but
their sequenceswere not conserved in relation to any known family
of Hymenopteran venom peptides. It may be considered that these
peptides are contaminants leaked from the venom glands during
reservoirs dissection, as already mentioned above. Anyway, their
functional characterization will require further investigation in the
future.
The mass chromatogram of the peptide-rich fraction (Fig. 1) was
used to determine the individual concentration of each peptide;
thus, it was observed that the most concentrated peptide compo-
nents in P. paulista venom were those from fractions 6A (Thr6-
Bradykinin), 10 (Polybia MP-VI), 11 (Polybia CP-2), and 13 (Polybia
MP-I), which occurred at levels of 460, 182, 360, and 550 ng/venom
gland, respectively. Meanwhile, the less abundant component was
that from fraction 17 (Polybia CP-3)which occurred at level of 16 ng/
venomgland. Thus,most prominent peptides fromP. paulistavenom
are the Thr6-Bradykinin, mastoparans, and chemotactic peptides.
5. Conclusion
P. paulista is a very aggressive social wasp that is endemic to
Southeast Brazil, where it causes many incidents of severe enve-
noming each year; the venom of this wasp was submitted to mass
spectrometric analysis to proﬁle its peptidome. Fourteen major
peptides were detected and sequenced. Five of them have already
been reported and characterized in previous publications. Nine of
them are novel toxins in P. paulista venom. The novel peptides
correspond to two wasp kinins, two chemotactic components,
three mastoparans, and two peptides of unknown function. The
novel peptides appear to act synergistically with the previously
known toxins and constitute three well-known families of peptide
toxins (wasp kinins, chemotactic peptides, and mastoparans). The
venom is used to promote mnemonic actions in sting victims
through the uncomfortable inﬂammatory response to the toxin
composition, and speciﬁcally the peptides (De Souza and Palma,
2009). These peptides are multifunctional toxins that cause a se-
ries of different actions (pain, oedema formation, haemolysis,
chemotaxis of PMNLs, and mast cell degranulation) in wasp sting
victims to generate a strong inﬂammatory response and cause
physical discomfort in the victims. Understanding the complex
matrix of peptides composing the venom of P. paulista will
contribute to a better understanding the complex mechanism of
pathogenesis caused by this venom.
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